Prévenir le VIH pendant la pandémie de COVID-19 : la PPE et la « PPE dans la poche » à la rescousse

HIV continues to be a global health threat, even amid the COVID-19 pandemic. In keeping with UNAIDS goals for reducing that burden, HIV prevention by PEP and PrEP have played major roles in reaching those goals. While PrEP has been instrumental in preventing HIV in people with high-risk exposures, we have seen gaps in HIV prevention strategies, especially among individuals who have less frequent exposures. This is where “pill-in-pocket PEP”, better known as PIP, has a substantial role to play.

Pour en savoir plus...

The promise that the COVID-19 vaccine brings: A hepatitis C nurse’s perspective

Winding through the basement of the hospital, past the spin studio that has been closed for a long time, I follow the snaking line of people. I stand on my designated dot on the floor, a reminder of the physical distancing measures we’ve all grown accustomed to this past year. I go through registration, and then into another line, multiple staff directing me at every turn, ensuring we respect the space and flow in this most circuitous of marathons. I sit down beside a nurse, who goes through the consent form one last time, as she picks up the needle...

Pour en savoir plus...

Accessing PrEP: The PrEPStart program in Ontario

Over the past five years, Ontario has seen a steady increase in the number of people using pre-exposure prophylaxis (PrEP). Between January and March 2020, 8,413 people were on PrEP – up from 289 in 2015. While most of these people live larger cities like Toronto and Ottawa, PrEP use has also increased in regions across the province.

Pour en savoir plus...

Understanding prescribing trends for hepatitis C treatment in Ontario

The introduction and wide availability of direct-acting antivirals (DAAs) as a treatment for hepatitis C through a phased rollout from 2015 to 2018 held the promise of expanded access to treatment. These simpler treatments carried fewer clinical restrictions and required less specialist support, opening the possibility for primary care providers to treat their patients with hepatitis C. Given barriers to healthcare access for people who use drugs, those of us at the Toronto Community Hep C Program were curious to find out if this had in fact happened.

Pour en savoir plus...

La COVID-19, les couvre-feux et la crise des surdoses : Une perspective québécoise

Pour mieux comprendre les enjeux et les priorités des personnes qui utilisent des drogues au Québec lors de la pandémie de COVID-19 et de la crise des surdoses, CATIE a mené une courte entrevue avec Frankie Lambert et Chantal Montmorency, deux membres de l’équipe de l’Association québécoise pour la promotion de la santé des personnes utilisatrices de drogues (AQPSUD). Voici ce qui tient à cœur à leur communauté.

Pour en savoir plus...